Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-15

FDA Approved: ZAFIRLUKAST — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Zafirlukast from Strides Pharma Science Limited. Zafirlukast is used for the prevention and chronic treatment of ast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zafirlukast (zafirlukast)

Snippet

SUPPL AP for ZAFIRLUKAST (ZAFIRLUKAST)